Skip to content

Feasibility of coronary access and re-intervention after transcatheter aortic valve implantation

Feasibility of coronary access and re-intervention after transcatheter aortic valve implantation - Feasibility of coronary access and re-intervention after transcatheter aortic valve implantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043488
Enrollment
300
Registered
2021-03-02
Start date
2021-03-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic stenosis

Interventions

None listed

Sponsors

Sakakibara Heart Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing TAVI for native aortic stenosis from March 2021 in Sakakibara Heart Institute.

Exclusion criteria

Exclusion criteria: death, no consent, debilitated condition, allergy of contrast media, renal dysfunction (eGFR<45)

Design outcomes

Primary

MeasureTime frame
1) feasibility of coronary access 2) feasibility of re-intervention

Countries

Japan

Contacts

Public ContactRyosuke Higuchi

Sakakibara Heart Institute Department of Cardiology

rhiguchi@shi.heart.or.jp042-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026